PROfortil is the only formulation that has six clinical studies1-5 demonstrating its efficacy and safety.
In a controlled study of 205 patients1, for example, PROfortil was superior to the control group in improving all key metrics for sperm quality – ejaculatory volume, cell density, motility and morphology.
More importantly, after three months of treatment with PROfortil26% of couples achieved pregnancy.
In a separate study2, PROfortil was given to male patients with subclinical varicocele. Post-treatment evaluation showed an improvement in all male fertility parameters, with pregnancy occurring in 41% of couples.
PROfortil is made in Austria with European-sourced ingredients and produced in compliance with Pharmaceutical Good Manufacturing Practices.
Red Leaf Medical Inc. is a proud member of BIOTECanada.